Traws Pharma share price logo

Traws Pharma

NASDAQ: TRAW

$0.60

-0.03

(-4.55%)

as on

Traws Pharma Stock Performance

as on October 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.59
    $0.68
    downward going graph

    1.26%

    Downside

    13.81%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.43
    $3.27
    downward going graph

    28.02%

    Downside

    446.44%

    Upside

    downward going graph

Traws Pharma share price movements today

Previous Close
$0.63
Open
$0.64
Volume
966.8K
Market Cap
$9.6M
Day's Low - High
$0.59 - $0.68
52 Week Low - High
$0.43 - $3.27

Traws Pharma Historical Returns

1 Month Return
+ 0.64 %
3 Month Return
-26.78 %
1 Year Return
-68.58 %
3 Year Return
0 %
5 Year Return
0 %

Traws Pharma Stock Fundamentals & Key Indicators

Check Traws Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.6M

EPS (TTM)

-0.61

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.15

Industry PE ratio

-3.05

PEG Ratio

-0.02

EBITDA

-15.5M

Revenue (TTM)

2.7M

Profit Margin

0.00%

Return On Equity TTM

353.43%

Traws Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Traws Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Traws Pharma image
Traws Pharma
Buy$9.6MNA-1.150.00%0.00%
Revolution Medicines image
Revolution Medicines
StrongBuy$43.8B604.88%-22.690.00%0.00%
Moderna image
Moderna
Neutral$81.2B-43.54%-24.76-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$133.4B189.75%30.3886.04%0.00%
Regeneron image
Regeneron
Buy$77.3B32.85%17.7984.86%0.49%

Stock Returns calculator for Traws Pharma Stock including INR - Dollar returns

The Traws Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Traws Pharma investment value today

Current value as on today

₹34,101

Returns

-₹65,899

(-65.9%)

Returns from Traws Pharma Stock

-₹68,386 (-68.39%)

Dollar Impact

₹2,487 (+2.49%)

Analyst Recommendation on Traws Pharma Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Traws Pharma. Average target price of $1

Traws Pharma Share Price Target

Get share price movements and forecasts by analysts on Traws Pharma.

What analysts predicted

40.25%UPSIDE

Target Price

$1

Current Price

$0.5975

Analyzed by

8 Analysts

Target

$1.00

Traws Pharma target price $1, a slight upside of 40.25% compared to current price of $0.5975. According to 8 analysts rating.

Indian Investors' Interest in Traws Pharma Stock

Search interest for Traws Pharma Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-60% versus previous 30 day period

Traws Pharma Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
2
-
-
Gross Profit
0
0
0
0
0
0
0
2
-
-
Operating Income
-7
-8
-11
-10
-9
-5
-8
-1
-7
-6
EBITDA
-7
-8
-11
-10
-9
-5
-8
-1
-7
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-8
-10
-10
-8
-4
-8
0
-7
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-7
-8
-10
-10
-8
-4
-8
0
-7
-3
Net Profit Margin
96.46%
100.00%
96.46%
100.00%
96.46%
100.00%
96.49%
100.00%
0.00%
0.00%

Traws Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Mar 2026
Total Revenue
0
1
2
0
0
0
0
0
2
Gross Profit
-
-
2
0
0
0
0
0
2
Operating Income
-25
-23
-21
-24
-16
-19
-20
-49
-17
EBITDA
-23
-20
-21
-24
-16
-19
-20
-166
-17
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-20
-21
-25
-16
-18
-18
-166
9
Income Tax Expense
0
0
0
0
-
-
-
-
-
Net Income
-24
-20
-21
-25
-16
-18
-18
-54
9
Net Profit Margin
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
94.69%
100.00%

Traws Pharma Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Mar 2026
Jun 2026
Net Income
-3
-4
-5
-4
-4
-123
81
0
-7
-7
Operating Cash Flow
-4
-4
-3
-4
-4
-9
-4
-5
-2
-2
Investing Cash Flow
-
-
-
-
-
-3
-
-
-
-
Financing Cash Flow
0
-
-
-
-
13
19
3
0
1
Change in Cash
-4
-4
-3
-4
-4
0
15
-2
-2
0

Traws Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Mar 2026
Net Income
-24
-20
-21
-25
-16
-18
-18
-166
9
Operating Cash Flow
-23
-22
-20
-23
-19
-16
-17
-29
-18
Investing Cash Flow
-
-
0
0
-
-
0
-3
-2
Financing Cash Flow
6
35
26
19
55
-
-
33
3
Change in Cash
-17
12
5
-3
36
-16
-17
0
-17

Global Institutional Holdings in Traws Pharma

Check out the Institutions with significant holdings in Traws Pharma.

Funds
Holdings
Vanguard
2.15%
Fidelity Concord Street Trust
0.37%
VANGUARD INDEX FUNDS
0.36%

Traws Pharma News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:03 PM

    -

    Traws Pharma reports Q3 2025 results, highlighting revenue growth and advancements in clinical programs for respiratory viral diseases.

Insights on Traws Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -7.44M → -3.05M (in $), with an average increase of 71.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TRAW stock has moved up by 11.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.2% return, outperforming this stock by 704.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.73M → 57.0K (in $), with an average decrease of 97.9% per quarter

About Traws Pharma

Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
OrganisationTraws Pharma
Headquarters12 Penns Trail, Newtown, PA, 18940, US
IndustryBiotechnology
CEOIain D. Dukes

Key Management of Traws Pharma

Name

Title

Dr. Iain D. Dukes DPHIL, M.A., Ph.D.

CEO, Secretary & Director

Dr. Nikolay Savchuk Ph.D.

COO & Director

Dr. Charles David Pauza Ph.D.

Chief Scientific Officer of Virology

Mr. Charles Parker

Chief Financial Officer

Dr. Victor Mandia Moyo M.D.

Chief Medical Officer of Oncology

Dr. Robert R. Redfield M.D.

Chief Medical Officer

FAQs

What is Traws Pharma share price today?

Traws Pharma share price today is $0.60 as on at the close of the market. Traws Pharma share today touched a day high of $0.68 and a low of $0.59.

What is the 52 week high and 52 week low for Traws Pharma share?

Traws Pharma share touched a 52 week high of $3.27 on and a 52 week low of $0.43 on . Traws Pharma stock price today i.e. is closed at $0.60,which is 81.70% down from its 52 week high and 38.92% up from its 52 week low.

What is Traws Pharma's market capitalisation today?

Traws Pharma market capitalisation is $0.00T as on .

How to invest in Traws Pharma Stock (TRAW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Traws Pharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Traws Pharma Stock (TRAW) from India?

Indian investors can start investing in Traws Pharma (TRAW) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Traws Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Traws Pharma share’s latest price of $0.60 as on October 1, 2026 at 1:29 am IST, you will get 16.7364 shares of Traws Pharma. Learn more about fractional shares .